trending Market Intelligence /marketintelligence/en/news-insights/trending/o4OKgAl0LoeM0BIRHIfR6A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Sedana Medical to raise 375M Swedish kronor from directed new share issue

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Sedana Medical to raise 375M Swedish kronor from directed new share issue

Sedana Medical AB (publ) launched a directed new share issue to raise 375 million Swedish kronor in gross proceeds from certain Swedish and international institutional investors.

The Sweden-based company, which develops and sells medical technology and devices, will sell 2,896,000 shares in the offering at 129.50 Swedish kronor apiece. Investors participating in the offering include AXA IM, Handelsbanken Fonder, Joh. Berenberg Gosslier & Co. KG, Swedbank Robur, the Third Swedish National Pension Fund and Öhman Fonder.

The company plans to use proceeds to fund activities leading to marketing authorization approval in the U.S. for AnaConDa, a disposable medical device that administers volatile anesthetics to mechanically ventilated patients, and IsoConDa, an inhalation therapy to sedate intensive care patients.

The company said it will not issue additional shares for six months after the announcement of the outcome of the directed new share issue.

Pareto Securities is the sole manager and book runner for the offering, while Roschier is legal adviser.

As of Oct. 11, US$1 was equivalent to 9.79 Swedish kronor.